What is the price target for ARMP stock?
8 analysts have analysed ARMP and the average price target is 15.3 USD. This implies a price increase of 79.16% is expected in the next year compared to the current price of 8.54.
ARMATA PHARMACEUTICALS INC (ARMP) Forecast, Price Target & Analyst Ratings
NYSEARCA:ARMP • US04216R1023
Current stock price
8.54 USD
-1.07 (-11.13%)
At close:
8.71 USD
+0.17 (+1.99%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARMATA PHARMACEUTICALS INC (ARMP).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.29
- Revenue Estimate
- 754.8K
Price Target Details & History
Consensus Price Target and Range
Mean target
$15.30
Upside
+ 79.16%
From current price of $8.54 to mean target of $15.30, Based on 8 analyst forecasts
Low
$15.15
Median
$15.30
High
$15.75
Price Target Revisions
1 Month
25.00%
3 Months
66.67%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for ARMP. The average price target is 15.3 USD. This implies a price increase of 79.16% is expected in the next year compared to the current price of 8.54.
The average price target has been revised upward by 66.67% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
ARMP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ARMP.
In the previous month the buy percentage consensus was at a similar level.
ARMP was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-05 | Jones Trading | Initiate | Buy |
| 2025-05-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-03-22 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 19, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.29
- Revenue Estimate
- 754.8K
- Revenue Q2Q
- -38.88%
- EPS Q2Q
- -508.00%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
ARMP is expected to report earnings on 3/19/2026. The consensus EPS estimate for the next earnings is -0.29 USD and the consensus revenue estimate is 754.80K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.51M 23.27% | 4.529M -17.80% | 5.174M 14.24% | 4.641M -10.30% | -100.00% | 57.419M | 27.54M -52.04% | 76.806M 178.89% | 146.57M 90.83% | 250.21M 70.71% | 376.58M 50.51% | ||
| EBITDA YoY % growth | -36.06M -59.14% | -39.918M -10.70% | -41.111M -2.99% | -31.722M 22.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -36.95M -55.06% | -40.89M -10.66% | -42.436M -3.78% | -32.181M 24.17% | -47.838M -48.65% | -59.466M -24.31% | -5.279M 91.12% | -43.452M -723.19% | 1.836M 104.23% | 59.466M 3,138.89% | 152.59M 156.60% | 273.77M 79.42% | |
| Operating Margin | -670.60% | -902.85% | -820.18% | -693.41% | N/A | N/A | -9.19% | -157.78% | 2.39% | 40.57% | 60.98% | 72.70% | |
| EPS YoY % growth | -1.09 -12.37% | -1.80 -65.14% | -0.52 71.11% | -1.67 -220.71% | -1.11 33.33% | -1.29 -15.60% | -0.09 92.86% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.29 -508.00% |
| Revenue Q2Q % growth | 754.8K -38.88% |
| EBITDA Q2Q % growth | -8.364M 9.23% |
| EBIT Q2Q % growth | -9.384M 10.96% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-35.20%
EPS Next 5 Year
16.20%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
37.47%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ARMATA PHARMACEUTICALS INC / ARMP Forecast FAQ
What is the next earnings date for ARMP stock?
ARMATA PHARMACEUTICALS INC (ARMP) will report earnings on 2026-03-19, after the market close.
What are the consensus estimates for ARMATA PHARMACEUTICALS INC (ARMP) next earnings?
The consensus EPS estimate for the next earnings of ARMATA PHARMACEUTICALS INC (ARMP) is -0.29 USD and the consensus revenue estimate is 754.80K USD.
What is the expected long term growth rate for ARMATA PHARMACEUTICALS INC (ARMP)?
The expected long term growth rate for ARMATA PHARMACEUTICALS INC (ARMP) is -25.99%.